Cargando…
The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease
β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effect...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651403/ https://www.ncbi.nlm.nih.gov/pubmed/34887998 http://dx.doi.org/10.1155/2021/7158444 |
_version_ | 1784611389359259648 |
---|---|
author | Wang, Nanbu Wang, Haoyu Pan, Qi Kang, Jian Liang, Ziwen Zhang, Ronghua |
author_facet | Wang, Nanbu Wang, Haoyu Pan, Qi Kang, Jian Liang, Ziwen Zhang, Ronghua |
author_sort | Wang, Nanbu |
collection | PubMed |
description | β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effects in degenerative disease. In this paper, we primarily explored the effects of the combination of β-asarone and ICA in clearing noxious proteins and reversing cognitive deficits. The accumulation of damaged mitochondria and mitophagy are hallmarks of aging and age-related neurodegeneration, including Alzheimer's disease (AD). Here, we provide evidence that autophagy/mitophagy is impaired in the hippocampus of APP/PS1 mice and in Aβ1-42-induced PC12 cell models. Enhanced mitophagic activity has been reported to promote Aβ and tau clearance in in vitro and in vivo models. Meanwhile, there is growing evidence that treatment of AD should be preceded by intervention before the formation of pathological products. The efficacy of the combination therapy was better than that of the individual therapies applied separately. Then, we found that the combination therapy also inhibited cell and mitochondrial damage by inducing autophagy/mitophagy. These findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis, and that combination treatment with mitophagy inducers represents a potential strategy for therapeutic intervention. |
format | Online Article Text |
id | pubmed-8651403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-86514032021-12-08 The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease Wang, Nanbu Wang, Haoyu Pan, Qi Kang, Jian Liang, Ziwen Zhang, Ronghua Oxid Med Cell Longev Research Article β-Asarone is the main constituent of Acorus tatarinowii Schott and exhibits important effects in diseases such as neurodegenerative and neurovascular diseases. Icariin (ICA) is a major active ingredient of Epimedium that has attracted increasing attention because of its unique pharmacological effects in degenerative disease. In this paper, we primarily explored the effects of the combination of β-asarone and ICA in clearing noxious proteins and reversing cognitive deficits. The accumulation of damaged mitochondria and mitophagy are hallmarks of aging and age-related neurodegeneration, including Alzheimer's disease (AD). Here, we provide evidence that autophagy/mitophagy is impaired in the hippocampus of APP/PS1 mice and in Aβ1-42-induced PC12 cell models. Enhanced mitophagic activity has been reported to promote Aβ and tau clearance in in vitro and in vivo models. Meanwhile, there is growing evidence that treatment of AD should be preceded by intervention before the formation of pathological products. The efficacy of the combination therapy was better than that of the individual therapies applied separately. Then, we found that the combination therapy also inhibited cell and mitochondrial damage by inducing autophagy/mitophagy. These findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis, and that combination treatment with mitophagy inducers represents a potential strategy for therapeutic intervention. Hindawi 2021-11-30 /pmc/articles/PMC8651403/ /pubmed/34887998 http://dx.doi.org/10.1155/2021/7158444 Text en Copyright © 2021 Nanbu Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wang, Nanbu Wang, Haoyu Pan, Qi Kang, Jian Liang, Ziwen Zhang, Ronghua The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title | The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title_full | The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title_fullStr | The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title_full_unstemmed | The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title_short | The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease |
title_sort | combination of β-asarone and icariin inhibits amyloid-β and reverses cognitive deficits by promoting mitophagy in models of alzheimer's disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651403/ https://www.ncbi.nlm.nih.gov/pubmed/34887998 http://dx.doi.org/10.1155/2021/7158444 |
work_keys_str_mv | AT wangnanbu thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT wanghaoyu thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT panqi thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT kangjian thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT liangziwen thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT zhangronghua thecombinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT wangnanbu combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT wanghaoyu combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT panqi combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT kangjian combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT liangziwen combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease AT zhangronghua combinationofbasaroneandicariininhibitsamyloidbandreversescognitivedeficitsbypromotingmitophagyinmodelsofalzheimersdisease |